Literature DB >> 16854183

[Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases].

Gustavo da Silva Rodrigues1, Rodrigo Rosa Ubatuba de Faria, Lucina Silva Guazzelli, Flávio de Mattos Oliveira, Luiz Carlos Severo.   

Abstract

Twenty two cases of nosocomial infection caused by Trichosporon asahii, detected during a period of six years (1999-2005) is described. The patients were predominantly males with an average age of 47.3 years-old. The predominant diseases in the study group were respiratory insufficiency, cancer, diabetes, chronic renal insufficiency, cirrhosis and AIDS. The main predisposing conditions were antibiotic therapy, mechanical ventilation, urethral catheterization, catheter, corticoids, transplant, immunosuppressive therapy, chemotherapy, granulocytopenia, surgical procedures and continuous ambulatory peritoneal dialysis. The most used antifungal drugs were fluconazole and amphotericin B. In some cases several antifungals were administered. Five patients did not receive antifungal treatment, and one patient received granulocyte colony stimulating factor (G-CSF). Nine patients showed clinical improvement, nine died and the progress of four patients is unknown. T. asahii is an emergent pathogen in patients with immunodeficiency and its presence in these type hosts can not be considered colonization, as there is an important risk of invasive infection. So, in susceptible patients to develop trichosporonosis it is advisable to take into consideration this disease especially in intensive clinical care units.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854183     DOI: 10.1016/s1130-1406(06)70019-5

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  8 in total

1.  Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.

Authors:  M Treviño; C García-Riestra; P Areses; X García; D Navarro; F J Suárez; I A López-Dequidt; O Zaragoza; M Cuenca-Estrella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-10       Impact factor: 3.267

2.  Onycholysis and Chromonychia: A Case Caused by Trichosporon inkin.

Authors:  María Fernanda Ortega-Springall; Sara Arroyo-Escalante; Roberto Arenas
Journal:  Skin Appendage Disord       Date:  2015-11-24

3.  Urinary tract infections due to Trichosporon spp. in severely ill patients in an intensive care unit.

Authors:  Maria das Graças Silva Mattede; Cláudio Piras; Kelly Dematte Silva Mattede; Aline Trugilho Ferrari; Lorena Simões Baldotto; Michel Silvestre Zouain Assbu
Journal:  Rev Bras Ter Intensiva       Date:  2015 Jul-Sep

4.  Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.

Authors:  Isabel Antonieta Iturrieta-González; Ana Carolina Barbosa Padovan; Fernando César Bizerra; Rosane Christine Hahn; Arnaldo Lopes Colombo
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 5.  Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.

Authors:  João N de Almeida Júnior; Christophe Hennequin
Journal:  Front Microbiol       Date:  2016-10-17       Impact factor: 5.640

Review 6.  On and Under the Skin: Emerging Basidiomycetous Yeast Infections Caused by Trichosporon Species.

Authors:  Marçal Mariné; Neil Andrew Brown; Diego Mauricio Riaño-Pachón; Gustavo Henrique Goldman
Journal:  PLoS Pathog       Date:  2015-07-30       Impact factor: 6.823

7.  Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies.

Authors:  Raquel M L Lemes; Juliana P Lyon; Leonardo M Moreira; Maria Aparecida de Resende
Journal:  Braz J Microbiol       Date:  2010-06-01       Impact factor: 2.476

8.  Genetic diversity and antifungal susceptibility testing of Trichosporon asahii isolated of Intensive Care Units patients.

Authors:  Rosana Bellan de Oliveira Silva; Ana Marisa Fusco-Almeida; Marcelo Teruyuki Matsumoto; Lilian Cristiane Baeza; Tatiane Benaducci; Maria José Soares Mendes-Giannini
Journal:  Braz J Microbiol       Date:  2008-09-01       Impact factor: 2.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.